STENOCARE A/S: Consolidation of founder's shareholdings

STENOCARE A/S
NASDAQ FIRST NORTH GROWTH MARKET, DENMARK
TICKER:  STENO

This information is information that STENOCARE A/S is obliged to publish in accordance with the EU Market Abuse Regulation. The information was provided by the contact person below for publication on Dec 21, 2023.

The three founders of STENOCARE A/S ("Stenocare") are merging their individual Holding Companies into a new Holding company named "SC Founders Holding ApS". The total ownership of STENOCARE shares is unchanged.

Change from: The three Stenocare founders have owned their Stenocare shares in three Holding companies since the Stenocare initial Public Offering (IPO) in October 2018. The three Holding companies are:

• Steno Group ApS, owning 1.671.697 Stenocare shares
• MS Kjær Holding ApS, owning 1.630.103 Stenocare shares
• Prana Holding ApS, owning 1.569.222 Stenocare shares

The total holdings for these three Holding companies are 4.871.022 Stenocare shares, This is equal to 32,25% of total shares before completion of the TO1 Warrant transaction and Directed Issues announced December 19, 2023.

Change to: The three founders have merged all their prior holdings of Stenocare shares into a new Holding company named "SC Founders Holding ApS", that owns a total of 4.871.022 Stenocare shares. This was equal to 32,25% of total shares before completion of the TO1 Warrant transaction and Directed Issues announced December 19, 2023. After the successful completion of the Directed Issues announced December 19, 2023 and the TO1 Warrant transaction announced December 21, 2023 - the new "SC Founders Holding ApS" own 26,50% of total shares. The three founders' shareholdings are carried into SC Founders Holding Aps with unchanged individual ownership of Stenocare shares. The only activity and objective of SC Founders Aps is to own shares in Stenocare.

• SC Founders Holding ApS, owning 4.871.022 Stenocare shares

The two Stenocare founders, that announced December 19 their participation in the Directed Issue, have made that investment via their personal accounts. Therefore, this is not included in the SC Founders Holding Aps ownership.

For additional information regarding STENOCARE, please contact:
Thomas Skovlund Schnegelsberg, CEO          Phone: [phone]            E-mail: [e-mail]

STENOCARE's Certified Adviser is Keswick Global AG / Phone: [phone] / E-mail: [e-mail]

About STENOCARE A/S
Stenocare was founded in 2017 with the purpose of supplying prescription-based medical cannabis to patients in Denmark and internationally. The company was first to receive the Danish Medicines Agency's permission to import, distribute as well as cultivate and produce medical cannabis. Stenocare sources its products from a number of carefully selected international high-quality suppliers and operates a unique, indoor state-of-the-art cultivation facility in Denmark, that has multiple levels of redundancy to safeguard quality and uniformity in a pesticide free production process.
www.stenocare.com    www.stenocare.dk

https://news.cision.com/stenocare/r/stenocare-a-s--consolidation-of-founder-s-shareholdings,c3898128

https://mb.cision.com/Main/17551/3898128/2511681.pdf

(c) 2023 Cision. All rights reserved., source Press Releases - English